|
Journal of Addiction Medicine
Online Submission and Review System
|
|
SCOPE
Journal of Addiction Medicine is a new peer reviewed journal
designed to address the needs of the professional practicing in the ever-changing
and challenging field of Addiction Medicine. Under the guidance of an
esteemed Editorial Board, the journal will cover a wide range of relevant
topics including:
- addiction in pregnancy
- adolescent addiction
- the drug exposed neonate
- pharmacology
- neuroimaging techniques
- treatment of special populations
- treatment of alcoholism and drug
- abuse
- pathological gambling disorder
- pathophysiology of addiction
- biological and nonbiological therapies
- issues in graduate medical education
ETHICAL/LEGAL CONSIDERATIONS
A submitted manuscript must be an original contribution not previously
published (except as an abstract or a preliminary report), must not be
under consideration for publication elsewhere, and, if accepted, must
not be published elsewhere in similar form, in any language, without
the consent of Lippincott Williams & Wilkins. Each person listed
as an author is expected to have participated in the study to a significant
extent.
Although the editors and referees make every effort to ensure the validity
of published manuscripts, the final responsibility rests with the authors,
not with the Journal, its editors, or the publisher. Authors are encouraged
to submit manuscripts on-line through the journal’s Web site at http://jam.edmgr.com.
Patient anonymity and informed consent: It is the author’s responsibility
to ensure that a patient’s anonymity be carefully protected and to
verify that any experimental investigation with human subjects reported
in the manuscript was performed with informed consent and following all
the guidelines for experimental investigation with human subjects required
by the institution(s) with which all the authors are affiliated. Unless
written consent is obtained and submitted with the manuscript, eyes should
be masked and names should be removed from figures.
Copyright
A copy of the Journal’s “Authorship Responsibility, Financial Disclosure, and Copyright Transfer” form must be signed by all authors and to the attention of:
Michael Arends, Managing Editor
Journal of Addiction Medicine
marends@scripps.edu
fax: 858-784-7450.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Permissions
Authors must submit written permission from the copyright owner (usually
the publisher) to use direct quotations, tables, or illustrations that
have appeared in copyrighted form elsewhere, along with complete details
about the source. Any permissions fees that might be required by the
copyright owner are the responsibility of the authors requesting use
of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
MANUSCRIPT SUBMISSION
All manuscripts must be submitted online through the new Web site at http://jam.edmgr.com. First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Michael A. Arends, Managing Editor, marends@scripps.edu; fax: 858-784-7450.
PREPARATION OF MANUSCRIPT
Manuscripts that do not adhere to the following instructions will be returned
to the corresponding author for technical revision before undergoing
peer review.
Title page
Include on the title page: (a) complete manuscript title; (b) authors’ full
names, highest academic degrees, and affiliations; (c) name and address
for correspondence, including fax number, telephone number, and e-mail
address; and (d) sources of support that require acknowledgment.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Key Words
Authors should provide 3–5 keywords for each article.
Abstract
Limit the abstract to 250 words. Do not cite references in the abstract.
Limit the use of abbreviations and acronyms. Original articles should
have a structured abstract organized under the following subheads: Objectives,
Methods, Results, and Conclusions.
Text
Organize the manuscript into five main headings: Methods, Results, Discussion,
Conclusions, and Acknowledgments. Define abbreviations at first mention
in text and in each table and figure. If a brand name is cited, supply
the manufacturer’s name and address (city and state/country). Acknowledge
all forms of support, including pharmaceutical and industry support,
in an Acknowledgment paragraph.
Abbreviations
For a list of standard abbreviations, consult the Council of Biology Editors
Style Guide (available from the Council of Science Editors, Drohan Management
Group, 12100 Sunset Hills Road, Suite 130, Reston, VA 20190) or other
standard sources. Write out the full term for each abbreviation at its
first use unless it is a standard unit of measure.
References
The authors are responsible for the accuracy of the references. Key the
references (double-spaced) at the end of the manuscript. Cite the references
in text in the order of appearance. Cite unpublished data—such
as papers submitted but not yet accepted for publication and personal
communications, including email communications—in parentheses in
the text. If there are more than three authors, name only the first three
authors and then use et al. Refer to the List of Journals Indexed in
Index Medicus for abbreviations of journal names, or access the list
at http://www.nlm.nih. gov/tsd/serials/lji.html. Sample references are
given below:
Journal article
1. Sakai K, Akima M, Saito K, et al. Nicorandil metabolism in rat myocardial
mitochondria. J Cardiovasc Pharmacol 2000;35:723–728.
Book chapter
2. Todd VR. Visual information analysis: frame of reference for visual
perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric
occupational therapy. Philadelphia: Lippincott Williams & Wilkins,
1999:205–256.
Entire book
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation. Philadelphia:
Lippincott Williams & Wilkins, 1999.
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for
Disease Control and Prevention; 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet
Gynecol [serial online]. January 1988;71:22–37. Available from:
BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute;
1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996.
Available at: http://www.amaassn.org/special/hiv/ethics. Accessed June
26, 1997.
Figures
Art should be created/scanned and saved and submitted as a TIFF (tagged
image file format), an EPS (encapsulated PostScript) file, or a PPT (PowerPoint)
file. Line art must have a resolution of at least 1200 dpi (dots per
inch), and electronic photographs, radiographs, CT scans, and so on,
and scanned images must have a resolution of at least 300 dpi. If fonts
are used in the artwork, they must be converted to paths or outlines
or they must be embedded in the files. Color images must be created/scanned
and saved and submitted as CMYK files. Please note that artwork generated
from office suite programs such as Corel-DRAW and MS Word and artwork
downloaded from the Internet (JPEG or GIF files) cannot be used. Illustrations
will not be redrawn; rather they are accepted as submitted. Cite figures
consecutively on the site, and number them in the order in which they
are discussed. All electronic art that cannot be successfully uploaded
must be submitted on a 3 1/2-inch high-density disk, a CD-ROM, or an
IomegaZip disk, accompanied by high-resolution laser prints of each image.
The journal accepts for publication color figures that will enhance an
article. Authors who submit color figures will receive an estimate of
the cost for color reproduction. If they decide not to pay for color
reproduction, they can request that the figures be converted to black
and white at no charge.
Digital art checklist:
- Create and submit artwork in the actual size it will appear in the journal
- Crop out any extra white or black space surrounding the image
- Text within figures should be in an acceptable font (Helvetica is preferred) and sized consistently throughout the artwork using 8–12 pt. type
- Text within figures should be embedded in the file or converted to an outline or path
- For black and white images: create and save in grayscale format
- For color files: create and save in CMYK format (not RGB)
- For line art: save and submit at a resolution of at least 1200 dpi
- For images/photographs: save and submit at a resolution of at least 300 dpi
- For combination halftones: save and submit at a resolution of at least 600 dpi
- For all artwork: save and submit TIFF or EPS files. Do not select “Save as Compressed TIFF” when saving files. PowerPoint files are also acceptable
- Save each figure as a separate file and save them separate from the accompanying text file(s). For multipanel or composite figures only: send as one file with each part labeled the way it is to appear in print
- Name figures in the format: corresponding author’s last name_figure1.tif, etc.
Detailed Figure Instructions:
For a step by step guide for submitting Digital Art to please visit www.LWWonline.com.
Click “For Authors” then click “Artwork” in
the menu to the right. Visit the “5 Steps for Creating
Digital Artwork” for specific guidelines.
Figure legends
Include legends for all figures. They should be brief and specific, and
they should appear on a separate manuscript page after the references.
Use scale markers in the image for electron micrographs, and indicate
the type of stain used.
Tables
Create tables using the table creating and editing feature of your word
processing software (e.g., Word, WordPerfect). Do not use Excel or comparable
spreadsheet programs. Group all tables in a separate file.
Cite tables consecutively in the text, and number them in that order. Each table should appear on a separate page and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style
Pattern manuscript style after the American Medical Association Manual
of Style (9th edition). Stedman’s Medical Dictionary (27th
edition) and Merriam Webster’s Collegiate Dictionary (10th
edition) should be used as standard references. Refer to drugs and therapeutic
agents by their accepted generic or chemical names, and do not abbreviate
them. Use code numbers only when a generic name is not yet available. In
that case, supply the chemical name and a figure giving the chemical structure
of the drug. Capitalize the trade names of drugs and place them in parentheses
after the generic names. To comply with trademark law, include the name
and (city and state/country) of the manufacturer of any drug, supply, or
equipment mentioned in the manuscript. Use the metric system to express
units of measure and degrees Celsius to express temperatures, and use SI
units rather than conventional units.
AFTER ACCEPTANCE
Page proofs and corrections
Corresponding authors will receive electronic page proofs to check the
copyedited and typeset article before publication. Portable document format
(PDF) files of the typeset pages and support documents (e.g., reprint order
form) will be sent to the corresponding author by e-mail. Complete instructions
will be provided with the e-mail for downloading and printing the files
and for faxing the corrected page proofs to the publisher. Those authors
without an e-mail address will receive traditional page proofs. It is the
author’s responsibility to ensure that there are no errors in the
proofs. Changes that have been made to conform to journal style will stand
if they do not alter the authors’ meaning. Only the most critical
changes to the accuracy of the content will be made. Changes that are stylistic
or are a reworking of previously accepted material will be disallowed.
The publisher reserves the right to deny any changes that do not affect
the accuracy of the content. Authors may be charged for alterations to
the proofs beyond those required to correct errors or to answer queries.
Proofs must be checked carefully and corrections faxed within 24 to 48
hours of receipt, as requested in the cover letter accompanying the page
proofs.
Reprints
Authors will receive a reprint order form and a price list with the page
proofs. Reprint requests should be returned with the corrected proofs,
if possible. Reprints are normally shipped 6 to 8 weeks after publication
of the issue in which the article appears. For any questions regarding
reprints or publication fees, contact the Reprint Department by mail
at Lippincott Williams & Wilkins, 351 West Camden Street, Baltimore,
MD 21201; by phone at 1–800-341–2258; by fax at 410-528-4434;
or by e-mail at: reprints@lww.com.
Publisher’s contact:
Fax corrected page proofs and any other related materials to Proof Manager,
Journal of Addiction Medicine, 410-558-6841.
